|
|
||||||||





* Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095;
Division of Infectious Diseases, Department of Medicine, Northwestern University Medical School, Chicago, IL 60611;
Emory University, Atlanta, GA 30329; and
Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM 87545
To investigate possible mechanisms behind HIV-1 escape from CTL, we performed detailed longitudinal analysis of Gag (SLYNTVATL)- and RT (ILKEPVHGV)-specific CTL responses and plasma epitope sequences in five individuals. Among those with CTL against consensus epitope sequences, epitope mutations developed over several years, invariably followed by decay of the CTL targeting the consensus epitopes. The maturation state of the CTL varied among individuals and appeared to affect the rate of epitope mutation and CTL decay, despite similar IFN-
production. Escape mutations were oligoclonal, suggesting fitness constraints. The timing of escape indicated that the net selective advantage of escape mutants was slight, further underscoring the importance of understanding factors determining selective pressure and viral fitness in vivo. Our data show surprisingly consistent decay of CTL responses after epitope escape mutation and provide insight into potential mechanisms for both immune failure and shifting CTL specificities.
This article has been cited by other articles:
![]() |
W. D. Wick, P. B. Gilbert, and O. O. Yang Predicting the Impact of Blocking Human Immunodeficiency Virus Type 1 Nef In Vivo J. Virol., March 1, 2009; 83(5): 2349 - 2356. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lichterfeld, D. Mou, T. D. H. Cung, K. L. Williams, M. T. Waring, J. Huang, F. Pereyra, A. Trocha, G. J. Freeman, E. S. Rosenberg, et al. Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors Blood, November 1, 2008; 112(9): 3679 - 3687. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Balamurugan, M. J. Lewis, C. M. R. Kitchen, M. N. Robertson, J. W. Shiver, E. S. Daar, J. Pitt, A. Ali, H. L. Ng, J. S. Currier, et al. Primary Human Immunodeficiency Virus Type 1 (HIV-1) Infection during HIV-1 Gag Vaccination J. Virol., March 15, 2008; 82(6): 2784 - 2791. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, J. McNevin, H. Zhao, D. M. Tebit, R. M. Troyer, M. McSweyn, A. K. Ghosh, D. Shriner, E. J. Arts, M. J. McElrath, et al. Evolution of Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitopes: Fitness-Balanced Escape J. Virol., November 15, 2007; 81(22): 12179 - 12188. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Karlsson, J. M. Chapman, B. D. Heiken, R. Hoh, E. G. Kallas, J. N. Martin, F. M. Hecht, S. G. Deeks, and D. F. Nixon Antiretroviral Drug Therapy Alters the Profile of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses and Shifts the Immunodominant Cytotoxic T-Lymphocyte Response from Gag to Pol J. Virol., October 15, 2007; 81(20): 11543 - 11548. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shin, S. D. Blackburn, J. N. Blattman, and E. J. Wherry Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection J. Exp. Med., April 16, 2007; 204(4): 941 - 949. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kan-Mitchell, M. Bajcz, K. L. Schaubert, D. A. Price, J. M. Brenchley, T. E. Asher, D. C. Douek, H. L. Ng, O. O. Yang, C. R. Rinaldo Jr., et al. Degeneracy and Repertoire of the Human HIV-1 Gag p1777-85 CTL Response. J. Immunol., June 1, 2006; 176(11): 6690 - 6701. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Draenert, T. M. Allen, Y. Liu, T. Wrin, C. Chappey, C. L. Verrill, G. Sirera, R. L. Eldridge, M. P. Lahaie, L. Ruiz, et al. Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus J. Exp. Med., March 20, 2006; 203(3): 529 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Allen, M. Altfeld, S. C. Geer, E. T. Kalife, C. Moore, K. M. O'Sullivan, I. DeSouza, M. E. Feeney, R. L. Eldridge, E. L. Maier, et al. Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution J. Virol., November 1, 2005; 79(21): 13239 - 13249. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Koibuchi, T. M. Allen, M. Lichterfeld, S. K. Mui, K. M. O'Sullivan, A. Trocha, S. A. Kalams, R. P. Johnson, and B. D. Walker Limited Sequence Evolution within Persistently Targeted CD8 Epitopes in Chronic Human Immunodeficiency Virus Type 1 Infection J. Virol., July 1, 2005; 79(13): 8171 - 8181. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Ibarrondo, P. A. Anton, M. Fuerst, H. L. Ng, J. T. Wong, J. Matud, J. Elliott, R. Shih, M. A. Hausner, C. Price, et al. Parallel Human Immunodeficiency Virus Type 1-Specific CD8+ T-Lymphocyte Responses in Blood and Mucosa during Chronic Infection J. Virol., April 1, 2005; 79(7): 4289 - 4297. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. O. Yang, E. S. Daar, B. D. Jamieson, A. Balamurugan, D. M. Smith, J. A. Pitt, C. J. Petropoulos, D. D. Richman, S. J. Little, and A. J. L. Brown Human Immunodeficiency Virus Type 1 Clade B Superinfection: Evidence for Differential Immune Containment of Distinct Clade B Strains J. Virol., January 15, 2005; 79(2): 860 - 868. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |